MCOLN1 and Alzheimer disease: These findings provide clear implications for our improved understanding of abnormalities in the EAL system in AD and other neurodegenerative diseases, highlight the mechanistic importance of TRPML1 endolysosomal Ca2+ signalling in these diseases and identify TRPML1 as a target for therapeutic intervention.